FLS-359

Pharmaceutical compound From Wikipedia, the free encyclopedia

FLS-359 is a drug which acts as a selective allosteric inhibitor of the enzyme sirtuin 2 (SIRT2). It has moderate potency, inhibiting SIRT2 with an IC50 of 3 μM, and shows broad-spectrum antiviral effects against both RNA and DNA viruses including hepatitis B and cytomegalovirus.[1][2][3]

Drug classSirtuin 2 (SIRT2) inhibitor
CAS Number
Quick facts Clinical data, Drug class ...
FLS-359
Clinical data
Drug classSirtuin 2 (SIRT2) inhibitor
Identifiers
  • 2-[7-(2,4-dimethylimidazol-1-yl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[(4-pyrazol-1-ylphenyl)methyl]-1,3-thiazole
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC27H26N6S
Molar mass466.61 g·mol−1
3D model (JSmol)
  • CC1=CN(C(=N1)C)C2=CC3=C(CCN(C3)C4=NC=C(S4)CC5=CC=C(C=C5)N6C=CC=N6)C=C2
  • InChI=1S/C27H26N6S/c1-19-17-32(20(2)30-19)25-9-6-22-10-13-31(18-23(22)15-25)27-28-16-26(34-27)14-21-4-7-24(8-5-21)33-12-3-11-29-33/h3-9,11-12,15-17H,10,13-14,18H2,1-2H3
  • Key:JRPPFSVORXBCPF-UHFFFAOYSA-N
Close

References

Related Articles

Wikiwand AI